We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

149 hedge funds and large institutions have $2.48B invested in Ironwood Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 63 increasing their positions, 39 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 39

23% more call options, than puts

Call options by funds: $12.9M | Put options by funds: $10.4M

7.5% more ownership

Funds ownership: 131.45% → 138.95% (+7.5%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

11% less funds holding

Funds holding: 167 → 149 (-18)

11% less capital invested

Capital invested by funds: $2.78B → $2.48B (-$305M)

54% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 28

Holders
149
Holders Change
-18
Holders Change %
-10.78%
% of All Funds
3.71%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
13
Increased
63
Reduced
39
Closed
28
Calls
$12.9M
Puts
$10.4M
Net Calls
+$2.44M
Net Calls Change
+$1.38M

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$46.3M
2
UBS AM
UBS AM
Illinois
+$46.1M
3
EC
EcoR1 Capital
California
+$28M
4
BM
Bridger Management
New York
+$23.2M
5
Deutsche Bank
Deutsche Bank
Germany
+$15.9M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$15.9M
2
Renaissance Technologies
Renaissance Technologies
New York
-$11.9M
3
Goldman Sachs
Goldman Sachs
New York
-$10.2M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$8.63M
5
Invesco
Invesco
Georgia
-$6.01M
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
151
Renaissance Technologies
New York
– -$11.9M -752,522 Closed
Invesco
152
Invesco
Georgia
– -$6.01M -380,078 Closed
FHAM
153
Folger Hill Asset Management
New York
– -$4.97M -314,057 Closed
Two Sigma Investments
154
Two Sigma Investments
New York
– -$2.61M -164,796 Closed
SIM
155
Spark Investment Management
New York
– -$2.25M -142,444 Closed
American Century Companies
156
American Century Companies
Missouri
– -$1.85M -117,051 Closed
ACM
157
Atika Capital Management
New York
– -$1.7M -107,460 Closed
SSA
158
Schonfeld Strategic Advisors
New York
– -$1.42M -90,041 Closed
ACM
159
Asymmetry Capital Management
California
– -$971K -61,405 Closed
AR
160
Advisory Research
Illinois
– -$914K -57,815 Closed
VRS
161
Virginia Retirement Systems
Virginia
– -$863K -54,566 Closed
Millennium Management
162
Millennium Management
New York
– -$628K -39,712 Closed
PCM
163
Prelude Capital Management
New York
– -$565K -35,701 Closed
JG
164
Jefferies Group
New York
– -$474K -29,954 Closed
QIM
165
Quantitative Investment Management
Virginia
– -$441K -27,940 Closed
NIT
166
NumerixS Investment Technologies
British Columbia, Canada
– -$327K -20,673 Closed
TI
167
Turner Investments
Pennsylvania
– -$302K -19,104 Closed
TSS
168
Two Sigma Securities
New York
– -$227K -14,344 Closed
PAM
169
Paradigm Asset Management
New York
– -$58.5K -3,701 Closed
CG
170
Cutler Group
California
– -$14.7K -1,071 Closed
PHK
171
Point72 Hong Kong
Hong Kong
– -$13K -823 Closed
Creative Planning
172
Creative Planning
Kansas
– -$3K -205 Closed
MAM
173
Meeder Asset Management
Ohio
– -$2K -137 Closed
DADC
174
D.A. Davidson & Co
Montana
– -$1K -119 Closed
IA
175
IFP Advisors
Florida
– -$1K -79 Closed
4 5 6
7
8

IRWD Hedge Fund Activity: Q3 2017 in Review

149 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q3 2017, worth a combined $2.48B — down 11% from $2.78B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of IRWD and 13 opened new positions — a net loss of 15 holders — while 39 trimmed existing stakes and 63 added.

The largest buyer was BVF Inc, opening a new position worth an estimated $46.3M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $15.9M sold.

  • 149 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q3 2017, down from 167 in Q2 2017.
  • Funds reported $2.48B of Ironwood Pharmaceuticals stock for Q3 2017, down 11% quarter-over-quarter.
  • 13 funds opened new Ironwood Pharmaceuticals positions in Q3 2017 and 28 closed out, a net change of -15 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q3 2017 was BVF Inc, an estimated $46.3M added.
  • The largest Ironwood Pharmaceuticals seller in Q3 2017 was Point72 Asset Management, an estimated $15.9M sold.

Based on aggregated 13F filings for Q3 2017.